554 related articles for article (PubMed ID: 32235902)
1. Understanding cachexia in the context of metastatic progression.
Biswas AK; Acharyya S
Nat Rev Cancer; 2020 May; 20(5):274-284. PubMed ID: 32235902
[TBL] [Abstract][Full Text] [Related]
2. The Etiology and Impact of Muscle Wasting in Metastatic Cancer.
Biswas AK; Acharyya S
Cold Spring Harb Perspect Med; 2020 Oct; 10(10):. PubMed ID: 31615873
[TBL] [Abstract][Full Text] [Related]
3. Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression.
Wu Q; Sun S; Li Z; Yang Q; Li B; Zhu S; Wang L; Wu J; Yuan J; Yang C; Li J; Sun S
Mol Cancer; 2018 Oct; 17(1):155. PubMed ID: 30359265
[TBL] [Abstract][Full Text] [Related]
4. Nonmuscle Tissues Contribution to Cancer Cachexia.
Argilés JM; Stemmler B; López-Soriano FJ; Busquets S
Mediators Inflamm; 2015; 2015():182872. PubMed ID: 26523094
[TBL] [Abstract][Full Text] [Related]
5. [Systemic and local mechanisms leading to cachexia in cancer].
Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
[TBL] [Abstract][Full Text] [Related]
6. The complex liaison between cachexia and tumor burden (Review).
De Lerma Barbaro A
Oncol Rep; 2015 Oct; 34(4):1635-49. PubMed ID: 26239384
[TBL] [Abstract][Full Text] [Related]
7. Endoplasmic Reticulum Stress, Calcium Dysregulation and Altered Protein Translation: Intersection of Processes That Contribute to Cancer Cachexia Induced Skeletal Muscle Wasting.
Isaac ST; Tan TC; Polly P
Curr Drug Targets; 2016; 17(10):1140-6. PubMed ID: 25882219
[TBL] [Abstract][Full Text] [Related]
8. [Pathogenesis of cachexia in malignant tumors].
Arkh Patol; 2005; 67(5):51-6. PubMed ID: 16323484
[TBL] [Abstract][Full Text] [Related]
9. Management of muscle wasting in cancer-associated cachexia: understanding gained from experimental studies.
Baracos VE
Cancer; 2001 Sep; 92(6 Suppl):1669-77. PubMed ID: 11598885
[TBL] [Abstract][Full Text] [Related]
10. Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.
Talbert EE; Guttridge DC
Semin Cell Dev Biol; 2016 Jun; 54():82-91. PubMed ID: 26385617
[TBL] [Abstract][Full Text] [Related]
11. Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison.
Masi T; Patel BM
Pharmacol Rep; 2021 Feb; 73(1):17-30. PubMed ID: 33141425
[TBL] [Abstract][Full Text] [Related]
12. Inter-tissue communication in cancer cachexia.
Argilés JM; Stemmler B; López-Soriano FJ; Busquets S
Nat Rev Endocrinol; 2018 Dec; 15(1):9-20. PubMed ID: 30464312
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of cancer cachexia: much more than host-tumour interaction?
Skipworth RJ; Stewart GD; Dejong CH; Preston T; Fearon KC
Clin Nutr; 2007 Dec; 26(6):667-76. PubMed ID: 17507116
[TBL] [Abstract][Full Text] [Related]
14. F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.
Sukari A; Muqbil I; Mohammad RM; Philip PA; Azmi AS
Semin Cancer Biol; 2016 Feb; 36():95-104. PubMed ID: 26804424
[TBL] [Abstract][Full Text] [Related]
15. mTOR and Tumor Cachexia.
Duval AP; Jeanneret C; Santoro T; Dormond O
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061533
[TBL] [Abstract][Full Text] [Related]
16. Impaired Muscle Regeneration in Cancer-Associated Cachexia.
Arneson PC; Doles JD
Trends Cancer; 2019 Oct; 5(10):579-582. PubMed ID: 31706505
[TBL] [Abstract][Full Text] [Related]
17. Energy metabolism in cachexia.
Rohm M; Zeigerer A; Machado J; Herzig S
EMBO Rep; 2019 Apr; 20(4):. PubMed ID: 30890538
[TBL] [Abstract][Full Text] [Related]
18. Physiologic and molecular characterization of a novel murine model of metastatic head and neck cancer cachexia.
Olson B; Norgard MA; Levasseur PR; Zhu X; Marks DL
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1312-1332. PubMed ID: 34231343
[TBL] [Abstract][Full Text] [Related]
19. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
20. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
Lima JDCC; Simoes E; de Castro G; Morais MRPT; de Matos-Neto EM; Alves MJ; Pinto NI; Figueredo RG; Zorn TMT; Felipe-Silva AS; Tokeshi F; Otoch JP; Alcantara P; Cabral FJ; Ferro ES; Laviano A; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1045-1059. PubMed ID: 31273954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
